| 3.695 0.075 (2.07%) | 12-08 13:08 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 4.52 | 1-year : | 5.27 |
| Resists | First : | 3.86 | Second : | 4.52 |
| Pivot price | 3.57  |
|||
| Supports | First : | 3.48 |
Second : | 3.24 |
| MAs | MA(5) : | 3.69  |
MA(20) : | 3.55 |
| MA(100) : | 3.88 |
MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 71.1 |
D(3) : | 74.5 |
| RSI | RSI(14): 54.3 |
|||
| 52-week | High : | 5.73 | Low : | 3.03 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CLVT ] has closed below upper band by 34.2%. Bollinger Bands are 11.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 3.82 - 3.85 | 3.85 - 3.87 |
| Low: | 3.55 - 3.57 | 3.57 - 3.6 |
| Close: | 3.59 - 3.62 | 3.62 - 3.66 |
Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.
Thu, 04 Dec 2025
Clarivate (CLVT) Unveils AI-Powered Regulatory Intelligence Tool - GuruFocus
Thu, 04 Dec 2025
Clarivate (NYSE: CLVT) rolls out Cortellis Regulatory AI Assistant for life sciences - Stock Titan
Thu, 04 Dec 2025
Clarivate Presents Cortellis Regulatory AI Assistant to Cut Through Complexity in Safety and Compliance - PR Newswire
Tue, 02 Dec 2025
Insider Sell: Bar Veinstein Sells 309,902 Shares of Clarivate PL - GuruFocus
Sun, 23 Nov 2025
William Blair Affirms Hold Stance as Clarivate Plc (CLVT) Q3 Net Loss Narrows - MSN
Thu, 13 Nov 2025
What Does Wall Street Think About Clarivate Plc (CLVT)? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Technology
|
|
|
Industry:
Information Technology Services
|
|
| Shares Out | 661 (M) |
| Shares Float | 387 (M) |
| Held by Insiders | 17 (%) |
| Held by Institutions | 89.6 (%) |
| Shares Short | 42,090 (K) |
| Shares Short P.Month | 38,220 (K) |
| EPS | -0.57 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 7.4 |
| Profit Margin | -15.9 % |
| Operating Margin | 7.1 % |
| Return on Assets (ttm) | 0.9 % |
| Return on Equity (ttm) | -7.6 % |
| Qtrly Rev. Growth | 0.1 % |
| Gross Profit (p.s.) | 2.47 |
| Sales Per Share | 3.77 |
| EBITDA (p.s.) | 1.41 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 610 (M) |
| Levered Free Cash Flow | 465 (M) |
| PE Ratio | -6.47 |
| PEG Ratio | 0 |
| Price to Book value | 0.49 |
| Price to Sales | 0.97 |
| Price to Cash Flow | 3.99 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|